ALERIS - RADIOLOGY acquired by MEINE RADIOLOGIE
Context
The divestment of Aleris' radiology arm to Meine Radiologie Holding (backed by EQT Infrastructure) marks a significant consolidation in the Nordic diagnostic imaging market. This transaction was executed in tandem with the sale of Aleris' primary care and rehab units to Praktikertjänst, as part of a broader strategic shift. The rationale for Aleris, under Triton's ownership, is to exit non-core segments to focus exclusively on becoming a specialized healthcare provider in Scandinavia. For the acquirer, the deal provides a major entry point into the Norwegian and Swedish markets, significantly expanding its existing German-focused radiology platform. The integration of 36 diagnostic units allows for significant scale advantages in procurement, technological investment, and standardized medical reporting. This move is consistent with the trend of private equity-backed platforms seeking to create pan-European leaders in capital-intensive medical sub-sectors like radiology.
ALERIS - RADIOLOGY, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
The radiology division of Aleris provides a comprehensive range of diagnostic imaging services through a network of 36 units across Scandinavia, specifically 14 locations in Norway and 22 in Sweden. The business model centers on performing over 1 million radiology exams annually, utilizing various modalities such as MRI, CT, and X-ray. It serves a diverse patient base, including those within the public healthcare system, insurance-covered individuals, and private-pay patients. By maintaining a large-scale regional footprint and specialized medical expertise, the division acts as a critical infrastructure partner for diagnostic services in the Nordic region. The operation is designed to deliver high-quality diagnostic accuracy and efficient patient throughput, supporting medical practitioners with essential imaging data for treatment planning and disease management.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2022 | ARDIAN | SIMAGO | FRANCE | Radiology |
| 04/2022 | GROUPE BRUXELLES LAMBERT | AFFIDEA | NETHERLANDS | Radiology |
| 01/2022 | WREN HOUSE | VOYAGE CARE | UNITED KINGDOM | Nursing Homes |
| 12/2021 | RAMSAY HEALTH CARE | ELYSIUM HEALTHCARE | UNITED KINGDOM | Clinics / Hospitals |
| 12/2021 | VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT | VIVALTO SANTÉ | FRANCE | Clinics / Hospitals |
| 11/2021 | CERBA HEALTHCARE | LABEXA | FRANCE | Labs (Biology) |
| 10/2021 | ARES / BPIFRANCE | POINT VISION | FRANCE | Ophthalmology |
| 10/2021 | IVC EVIDENSIA | VETONE | FRANCE | Vet Clinics |
| 10/2021 | THE CRANEMERE GROUP | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Radiology |
| 09/2021 | LIVINGBRIDGE | EVERLIGHT RADIOLOGY | UNITED KINGDOM | Radiology |
REFERENCES
Valuation range: EV 300M - 700M EUR
EBITDA range: 10M - 30M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALERIS - RADIOLOGY by MEINE RADIOLOGIE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: aleris - radiology